There are probably some positions still to be unwound here and the stock may not react as we all hope and deserve to expect but the great news here is that the overall fundamentals of USRM are good and getting better. They also have the added appeal of "BREAK AWAY" news from FDA. This stock will undoubtedly be higher each month as the results of their new clinics show additional revs. Its now a matter of if the company will be slugging it out alone and growing organically or if a "Big Brother" steps in. Either way the next 12 mos will be rewarding to shareholders.
Market Data 
Markets 
AI
